For the year ending 2025-12-31, MRMD had $1,602K increase in cash & cash equivalents over the period. $6,528K in free cash flow.
| Cash Flow | 2025-12-31 |
|---|---|
| Net loss attributable to common stockholders | -14,484 |
| Net income attributable to noncontrolling interests | 28 |
| Depreciation and amortization of property and equipment | 8,109 |
| Amortization of intangible assets | 3,401 |
| Stock-based compensation | 1,860 |
| Amortization of warrants issued as payment for services received | 0 |
| Amortization of debt discount | 459 |
| Amortization of debt issuance costs | 73 |
| Payment-in-kind interest | 30 |
| Bad debt expense (income) | 1,582 |
| Obligations settled with common stock | 3 |
| Loss on disposal of assets | -834 |
| Loss on changes in fair value of investments | 0 |
| Accounts receivable, net | 429 |
| Inventory | 6 |
| Deferred rents receivable | -12 |
| Other current assets | -1,035 |
| Other assets | 2,606 |
| Accounts payable | 841 |
| Accrued expenses and other | 3,162 |
| Deferred revenue | 65 |
| Income taxes payable | 3,726 |
| Net cash provided by operating activities | 7,695 |
| Purchases of property and equipment | 1,167 |
| Business acquisitions, net of cash acquired | -231 |
| Advances toward future business acquisitions | 50 |
| Purchases and renewals of cannabis licenses | 465 |
| Proceeds from notes receivable | 26 |
| Return on investment | 0 |
| Proceeds from disposal of assets | 45 |
| Due from third party | 0 |
| Net cash used in investing activities | -1,380 |
| Proceeds from construction to permanent commercial real estate mortgage loan | 0 |
| Proceeds from mortgages | 2,000 |
| Payment of third-party debt issuance costs in connection with debt | 9 |
| Principal payments of mortgages | 1,495 |
| Repayment and retirement of mortgages | 689 |
| Principal payments of promissory notes | 3,066 |
| Principal payments of finance leases | 1,317 |
| Distributions | 137 |
| Net cash (used in) provided by financing activities | -4,713 |
| Net increase (decrease) to cash, cash equivalents and restricted cash | 1,602 |
| Cash, cash equivalents and restricted cash at beginning of year | 7,282 |
| Cash, cash equivalents and restricted cash at end of year | 8,884 |
MARIMED INC. (MRMD)
MARIMED INC. (MRMD)